Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis

Biochemical Pharmacology

Volumn 77, Issue 5, 2009, Pages 845-857

  Di Paola, Rosanna ^a   Esposito, Emanuela ^a,b   Mazzon, Emanuela ^a   Riccardi, Luisa ^c   Caminiti, Rocco ^d   Dal Toso, Roberto ^e   Pressi, Giovanna ^e   Cuzzocrea, Salvatore ^a,d  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e IRB Srl   (Italy)

Author keywords

Adhesion molecules; Colitis; MMP9 (matrix metallopeptidase 9); Teupolioside

Indexed keywords

3 NITROTYROSINE; DINITROBENZENESULFONIC ACID; GELATINASE A; GELATINASE B; GLYCOSIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MALONALDEHYDE; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROBENZENE DERIVATIVE; PADGEM PROTEIN; PHENYLPROPANOID GLYCOSIDE; TEUPOLIOSIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AJUGA; AJUGA REPTANS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOTECHNOLOGY; COLITIS; COLON INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIARRHEA; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLANT CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; UPREGULATION; WEIGHT REDUCTION;

AJUGA; ANIMALS; BENZENESULFONATES; CAFFEIC ACIDS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS; COLON; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; LIPID PEROXIDATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE TYPE II; P-SELECTIN; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRISACCHARIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59749094375     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.11.010     Document Type: Article

References (33)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Fiocchi C. Inflammatory bowel disease pathogenesis: therapeutic implications. Chin J Dig Dis 6 (2005) 6-9
3. Jump R.L., and Levine A.D. Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease. Inflamm Bowel Dis 10 (2004) 462-478
4. Stallmach A., Strober W., MacDonald T.T., Lochs H., and Zeitz M. Induction and modulation of gastrointestinal inflammation. Immunol Today 19 (1998) 438-441
5. Podolsky D.K., and Nutrition. Crohn's disease. J Gastroenterol 35 Suppl 12 (2000) 18
6. Babbs C.F. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13 (1992) 169-181
7. Rezaie A., Parker R.D., and Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?. Dig Dis Sci 52 (2007) 2015-2021
8. Keshavarzian A., Morgan G., Sedghi S., Gordon J.H., and Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut 31 (1990) 786-790
9. Middleton Jr. E. Some biological properties of plant flavonoids. Ann Allergy 61 (1988) 53-57
10. Denisov A.I., and Afanas'ev V.I. Biological bases of posthodiplostomatosis control in pond fish. Veterinariia 7 (1973) 63-65
11. Kurkin V.A. Phenylpropanoids from medicinal plants: distribution, classification, structural analysis, and biological activity. Chem Nat Compd 39 (2003) 123-153
12. Lee J.Y., Woo E.R., and Kang K.W. Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J Ethnopharmacol 97 (2005) 561-566
13. Tognolini M., Barocelli E., Ballabeni V., Bruni R., Bianchi A., Chiavarini M., et al. Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity. Life Sci 78 (2006) 1419-1432
14. Hsu S. Green tea and the skin. J Am Acad Dermatol 52 (2005) 1049-1059
15. Kris-Etherton P.M., Hecker K.D., Bonanome A., Coval S.M., Binkoski A.E., Hilpert K.F., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113 Suppl 9B (2002) 71S-88S
16. Korkina L., Mikhal'chik E., Suprun M., Pastore S., and DT R. Molecular mechanisms underlying wound healing and anti-inflammatory properties of naturally occurring biotechnologically produced phenylpropanoid glycosides. Cell Mol Biol 53 (2006) 78-83
17. Mullane K.M., Kraemer R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14 (1985) 157-167
18. Riccardi L, Mazzon E, Bruscoli S, Esposito E, Crisafulli C, Di Paola R, Caminiti R, Riccardi C, Cuzzocrea S. PPAR-alpha modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice. Shock; July 24, 2008. [Epub ahead of print].
19. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
20. Strober W., Fuss I., and Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 117 (2007) 514-521
21. Neurath M.F., Finotto S., Fuss I., Boirivant M., Galle P.R., and Strober W. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 22 (2001) 21-26
22. MacDonald T.T., Bajaj-Elliott M., and Pender S.L. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today 20 (1999) 505-510
23. Shapiro H., Singer P., Halpern Z., and Bruck R. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut 56 (2007) 426-435
24. Lu Y., and Wahl L.M. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J Leukoc Biol 78 (2005) 259-265
25. Medina C., and Radomski M.W. Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther 318 (2006) 933-938
26. Ji L.L., Gomez-Cabrera M.C., and Vina J. Role of nuclear factor kappaB and mitogen-activated protein kinase signaling in exercise-induced antioxidant enzyme adaptation. Appl Physiol Nutr Metab 32 (2007) 930-935
27. Cross R.K., and Wilson K.T. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 9 (2003) 179-189
28. Therond P. Oxidative stress and damages to biomolecules (lipids, proteins, DNA). Ann Pharm Fr 64 (2006) 383-389
29. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9 (1996) 836-844
30. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
31. Giovannelli L., Cozzi A., Guarnieri I., Dolara P., and Moroni F. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors. J Cereb Blood Flow Metab 22 (2002) 697-704
32. Mandir A.S., Poitras M.F., Berliner A.R., Herring W.J., Guastella D.B., Feldman A., et al. NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J Neurosci 20 (2000) 8005-8011
33. Penberthy T.W., Jiang Y., and Graves D.T. Leukocyte adhesion molecules. Crit Rev Oral Biol Med 8 (1997) 380-388